Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.27.1 (
RNase
)
16,360
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sam68
is a target of the c-Src tyrosine kinase. We previously showed that overexpression of
Sam68
functionally substitutes for, as well as synergies with, HIV-1 Rev in Rev-response element (RRE)-mediated gene expression and virus replication. Here we describe the identification of heterogeneous nuclear ribonucleoprotein K (hnRNP K) as a protein that specifically interacts with
Sam68
in vitro and in vivo. HnRNP K did not bind to RRE-RNA directly, but formed a super complex with
Sam68
and RRE in vitro.
RNase
treatment did not change the strength of binding of hnRNP K to
Sam68
. We demonstrated that hnRNP K significantly inhibited
Sam68
-mediated, but not Rev-mediated, RRE-dependent gene expression. We further showed that
Sam68
, but not a non-functional mutant Sam68p21, inhibited transcriptional activation of CT element by hnRNP K. Interestingly, the Sam68p21 with a single amino acid substitution in the nuclear localization domain exhibited less affinity for hnRNP K in vitro. We propose that the direct interaction of
Sam68
and hnRNP K adversely affect the activities of both proteins in signal transduction pathways of both transcriptional and post-transcriptional events.
...
PMID:Functional interaction of Sam68 and heterogeneous nuclear ribonucleoprotein K. 1237 Aug 8
Human immunodeficiency virus type 1 (HIV-1) replication requires active nuclear export of unspliced and incompletely spliced HIV-1 RNA transcripts. This process is evolutionally made possible by expression of HIV-1 Rev, one of the three HIV-1 proteins encoded by completely spliced HIV-1 RNAs. Evidence has accumulated to suggest that
Sam68
plays an important role in HIV-1 replication through HIV-1 Rev protein. In the present study, we further examined the structure-function relationship of
Sam68
protein in relation to HIV-1 replication. We identified a
Sam68
domain located between aa269 and aa321 to be involved in the HIV-inhibitory effects of
Sam68
dominant negative mutants lacking the nuclear localization signal (NLS). Deletion of this domain abrogated inhibition of HIV-1 replication by these mutants. HIV-1 Rev protein appeared to mediate the HIV-inhibitory effects of these mutants and by this domain, as assessed by Rev-dependent chloramphenicol acetyltransferase reporter gene assay, in trans rev-defective HIV-1 complementation assay, and
RNase
protection assay. The HIV-inhibitory mutants containing this domain were further found to have diminished binding affinity to the wild-type
Sam68
and to be associated with cytoplasmic retention of exclusively nuclear localized wild type
Sam68
. Taken together, these results further ascertain the important role of
Sam68
in HIV-1 Rev function and viral replication, and suggest that the HIV-inhibitory effects of
Sam68
dominant negative mutants directly result from their binding to endogenous
Sam68
and their interference with nuclear localization of endogenous
Sam68
.
...
PMID:Requirement of an additional Sam68 domain for inhibition of human immunodeficiency virus type 1 replication by Sam68 dominant negative mutants lacking the nuclear localization signal. 1623 70
Sam68
plays an essential role in mouse spermatogenesis and male fertility. Herein, we report an interaction between
Sam68
and the phosphorylated forms of the RNA polymerase II (RNAPII) in meiotic spermatocytes.
RNase
treatment decreased but did not abolish the interaction, consistently with in vitro binding of RNAPII to the
Sam68
carboxyl-terminal region.
Sam68
retention in the spermatocyte nucleus was dependent on the integrity of cellular RNAs, suggesting that the protein is recruited to transcriptionally active chromatin. Mouse knockout models characterized by stage-specific arrest of spermatogenesis and staining with the phosphorylated form of RNAPII documented that
Sam68
expression is confined to the transcriptionally active stages of spermatogenesis. Furthermore,
Sam68
associates with splicing regulators in germ cells and we report that alternative splicing of Sgce exon 8 is regulated in a
Sam68
-dependent manner during spermatogenesis. RNA and chromatin crosslink immunoprecipitation experiments showed that
Sam68
binds in vivo to sequences surrounding the intron 7/exon 8 boundary, thereby affecting the recruitment of the phosphorylated RNAPII and of the general splicing factor U2AF65. These results suggest that
Sam68
regulates alternative splicing at transcriptionally active sites in differentiating germ cells and provide new insights into the regulation of
Sam68
expression during spermatogenesis.
...
PMID:Sam68 marks the transcriptionally active stages of spermatogenesis and modulates alternative splicing in male germ cells. 2135 37
The mammalian cell nucleus contains membraneless suborganelles referred to as nuclear bodies (NBs). Some NBs are formed with an architectural RNA (arcRNA) as the structural core. Here, we searched for new NBs that are built on unidentified arcRNAs by screening for
ribonuclease
(
RNase
)-sensitive NBs using 32,651 fluorescently tagged human cDNA clones. We identified 32 tagged proteins that required RNA for their localization in distinct nuclear foci. Among them, seven RNA-binding proteins commonly localized in the
Sam68
nuclear body (SNB), which was disrupted by
RNase
treatment. Knockdown of each SNB protein revealed that SNBs are composed of two distinct
RNase
-sensitive substructures. One substructure is present as a distinct NB, termed the DBC1 body, in certain conditions, and the more dynamic substructure including
Sam68
joins to form the intact SNB. HNRNPL acts as the adaptor to combine the two substructures and form the intact SNB through the interaction of two sets of RNA recognition motifs with the putative arcRNAs in the respective substructures.
...
PMID:The Sam68 nuclear body is composed of two RNase-sensitive substructures joined by the adaptor HNRNPL. 2737 49